Cargando…

Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder

IMPORTANCE: There exist limited data on the long-term concurrent use of stimulants and opioids among adults with attention-deficit/hyperactivity disorder (ADHD), a population at risk for prescription drug abuse. OBJECTIVE: To assess the prevalence and secular trends of and the factors associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Yu-Jung Jenny, Zhu, Yanmin, Liu, Wei, Bussing, Regina, Winterstein, Almut G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324259/ https://www.ncbi.nlm.nih.gov/pubmed/30646105 http://dx.doi.org/10.1001/jamanetworkopen.2018.1152

Ejemplares similares

Association of Timing and Duration of Prenatal Analgesic Opioid Exposure With Attention-Deficit/Hyperactivity Disorder in Children
por: Trønnes, Johanne Naper, et al.
Publicado: (2021)

Association of Perinatal and Childhood Ischemic Stroke With Attention-Deficit/Hyperactivity Disorder
por: Bolk, Jenny, et al.
Publicado: (2022)

Attention-Deficit/Hyperactivity Disorder and Mortality Risk in Taiwan
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2019)

Adult Attention-Deficit/Hyperactivity Disorder and the Risk of Dementia
por: Levine, Stephen Z., et al.
Publicado: (2023)

Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder
por: Sultan, Ryan S., et al.
Publicado: (2019)

Psychiatric Comorbidities and Schizophrenia in Youths With Attention-Deficit/Hyperactivity Disorder
por: Jeon, Soo Min, et al.
Publicado: (2023)

Association of Attention-Deficit/Hyperactivity Disorder Diagnosis With Adolescent Quality of Life
por: Kazda, Luise, et al.
Publicado: (2022)

Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups
por: Chung, Winston, et al.
Publicado: (2019)

Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit/Hyperactivity Disorder During Adolescence
por: McCabe, Sean Esteban, et al.
Publicado: (2023)

Concurrent use of prescription gabapentinoids with opioids and risk for fall-related injury among older US Medicare beneficiaries with chronic noncancer pain: A population-based cohort study
por: Chen, Cheng, et al.
Publicado: (2022)

Evaluation of Attention-Deficit/Hyperactivity Disorder Medications, Externalizing Symptoms, and Suicidality in Children
por: Shoval, Gal, et al.
Publicado: (2021)

Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016
por: Xu, Guifeng, et al.
Publicado: (2018)

Association of Genetic and Environmental Risks for Attention-Deficit/Hyperactivity Disorder With Hypomanic Symptoms in Youths
por: Hosang, Georgina M., et al.
Publicado: (2019)

Association of Attention-Deficit/Hyperactivity Disorder With Teenage Birth Among Women and Girls in Sweden
por: Skoglund, Charlotte, et al.
Publicado: (2019)

Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review
por: Kazda, Luise, et al.
Publicado: (2021)

Association Between Periconceptional Weight of Maternal Grandmothers and Attention-Deficit/Hyperactivity Disorder in Grandchildren
por: Yim, Gyeyoon, et al.
Publicado: (2021)

Association of Prenatal Exposure to Benzodiazepines With Development of Autism Spectrum and Attention-Deficit/Hyperactivity Disorders
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2022)

Motor Vehicle Crash Risk in Older Adult Drivers With Attention-Deficit/Hyperactivity Disorder
por: Liu, Yuxin, et al.
Publicado: (2023)

Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial
por: Lam, Alexandra P., et al.
Publicado: (2019)

Association Between Pharmacological Treatment of Attention-Deficit/Hyperactivity Disorder and Long-term Unemployment Among Working-Age Individuals in Sweden
por: Li, Lin, et al.
Publicado: (2022)

Combined Medication with Stimulants and Non-stimulants for Attention-deficit/hyperactivity Disorder
por: Bahn, Geon Ho, et al.
Publicado: (2021)

Methylphenidate improves response inhibition but not reflection–impulsivity in children with attention deficit hyperactivity disorder (ADHD)
por: DeVito, Elise E., et al.
Publicado: (2008)

Association Between Greenness Surrounding Schools and Kindergartens and Attention-Deficit/Hyperactivity Disorder in Children in China
por: Yang, Bo-Yi, et al.
Publicado: (2019)

Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth Cohort
por: Shi, Yu, et al.
Publicado: (2021)

Association of Maternal Use of Triptans During Pregnancy With Risk of Attention-Deficit/Hyperactivity Disorder in Offspring
por: Harris, Gerd Marie, et al.
Publicado: (2022)

Association of Prenatal Exposure to Benzodiazepines and Z-Hypnotics With Risk of Attention-Deficit/Hyperactivity Disorder in Childhood
por: Sundbakk, Lene Maria, et al.
Publicado: (2022)

Treatment of US Children With Attention-Deficit/Hyperactivity Disorder in the Adolescent Brain Cognitive Development Study
por: Olfson, Mark, et al.
Publicado: (2023)

Stimulant Induced Movement Disorders in Attention Deficit Hyperactivity Disorder
por: Nam, Seok-Hyun, et al.
Publicado: (2022)

Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring
por: Christensen, Jakob, et al.
Publicado: (2019)

Association of Exposure to Endocrine-Disrupting Chemicals During Adolescence With Attention-Deficit/Hyperactivity Disorder–Related Behaviors
por: Shoaff, Jessica R., et al.
Publicado: (2020)

Association of Relative Age in the School Year With Diagnosis of Intellectual Disability, Attention-Deficit/Hyperactivity Disorder, and Depression
por: Root, Adrian, et al.
Publicado: (2019)

Individual and Combined Association Between Prenatal Polysubstance Exposure and Childhood Risk of Attention-Deficit/Hyperactivity Disorder
por: Garrison-Desany, Henri M., et al.
Publicado: (2022)

Machine Learning–Based Prediction of Attention-Deficit/Hyperactivity Disorder and Sleep Problems With Wearable Data in Children
por: Kim, Won-Pyo, et al.
Publicado: (2023)

Long-term effects of stimulants on neurocognitive performance of Taiwanese children with attention-deficit/hyperactivity disorder
por: Tsai, Ching-Shu, et al.
Publicado: (2013)

Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study
por: Wei, Yu-Jung Jenny, et al.
Publicado: (2019)

Prevalence of Attention Deficit Hyperactivity Disorder in primary school children
por: Venkata, Jyothsna Akam, et al.
Publicado: (2013)

Prevalence of attention deficit hyperactivity disorder symptoms in patients with schizophrenia
por: Arican, I., et al.
Publicado: (2018)

Long-Term Stimulant Treatment Affects Brain Dopamine Transporter Level in Patients with Attention Deficit Hyperactive Disorder
por: Wang, Gene-Jack, et al.
Publicado: (2013)

Prevalence and correlates of attention-deficit hyperactivity disorder symptoms in Korean college students
por: Kwak, Young-Sook, et al.
Publicado: (2015)

Trajectories of prescription opioid dose and risk of opioid-related adverse events among older Medicare beneficiaries in the United States: A nested case–control study
por: Wei, Yu-Jung Jenny, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lu5jhd2lesqu1i5aiupfsvupmd